Literature DB >> 28560632

Improvements in brain and behavior following eradication of hepatitis C.

Taylor Kuhn1,2, Philip Sayegh3, Jacob D Jones4,5, Jason Smith5, Manoj K Sarma4, A Ragin4, Elyse J Singer6, M Albert Thomas4, April D Thames4, Steven A Castellon4,5, Charles H Hinkin4,5.   

Abstract

Despite recent advances in treatment, hepatitis C remains a significant public health problem. The hepatitis C virus (HCV) is known to infiltrate the brain, yet findings from studies on associated neurocognitive and neuropathological changes are mixed. Furthermore, it remains unclear if HCV eradication improves HCV-associated neurological compromise. This study examined the longitudinal relationship between neurocognitive and neurophysiologic markers among healthy HCV- controls and HCV+ adults following successful HCV eradication. We hypothesized that neurocognitive outcomes following treatment would be related to both improved cognition and white matter integrity. Participants included 57 HCV+ participants who successfully cleared the virus at the end of treatment (sustained virologic responders [SVRs]) and 22 HCV- controls. Participants underwent neuropsychological testing and, for a nested subset of participants, neuroimaging (diffusion tensor imaging) at baseline and 12 weeks following completion of HCV therapy. Contrary to expectation, group-level longitudinal analyses did not reveal significant improvement in neurocognitive performance in the SVRs compared to the control group. However, a subgroup of SVRs demonstrated a significant improvement in cognition relative to controls, which was related to improved white matter integrity. Indeed, neuroimaging data revealed beneficial effects associated with clearing the virus, particularly in the posterior corona radiata and the superior longitudinal fasciculus. Findings suggest that a subgroup of HCV+ patients experienced improvements in cognitive functioning following eradication of HCV, which appears related to positive changes in white matter integrity. Future research should examine whether any additional improvements in neurocognition and white matter integrity among SVRs occur with longer follow-up periods.

Entities:  

Keywords:  Diffusion tensor imaging; Hepatitis C virus; Neurocognition; Neuropathology; Sustained virologic response; White matter integrity

Mesh:

Year:  2017        PMID: 28560632      PMCID: PMC5623101          DOI: 10.1007/s13365-017-0533-0

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  44 in total

1.  Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.

Authors:  M Bokemeyer; X-Q Ding; A Goldbecker; P Raab; M Heeren; D Arvanitis; H L Tillmann; H Lanfermann; K Weissenborn
Journal:  Gut       Date:  2010-10-06       Impact factor: 23.059

Review 2.  The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation.

Authors:  D Shawcross; R Jalan
Journal:  Cell Mol Life Sci       Date:  2005-10       Impact factor: 9.261

3.  Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Raul Gonzalez; Emily Conover; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

4.  Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Authors:  Brian R Edlin; Benjamin J Eckhardt; Marla A Shu; Scott D Holmberg; Tracy Swan
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

5.  Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease.

Authors:  Daniel M Forton; Howard C Thomas; Christine A Murphy; Joanna M Allsop; Graham R Foster; Janice Main; Keith A Wesnes; Simon D Taylor-Robinson
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

6.  Hepatitis C virus infection and neurocognitive function.

Authors:  M Soogoor; H S Lynn; S M Donfield; E Gomperts; T S Bell; E S Daar
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

7.  Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.

Authors:  Joanna Bladowska; Anna Zimny; Anna Kołtowska; Paweł Szewczyk; Brygida Knysz; Jacek Gąsiorowski; Michał Furdal; Marek J Sąsiadek
Journal:  Eur J Radiol       Date:  2012-12-14       Impact factor: 3.528

8.  Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants.

Authors:  Daniel M Forton; Peter Karayiannis; Nadiya Mahmud; Simon D Taylor-Robinson; Howard C Thomas
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Simplified criteria for the diagnosis of autoimmune hepatitis.

Authors:  Elke M Hennes; Mikio Zeniya; Albert J Czaja; Albert Parés; George N Dalekos; Edward L Krawitt; Paulo L Bittencourt; Gilda Porta; Kirsten M Boberg; Harald Hofer; Francesco B Bianchi; Minoru Shibata; Christoph Schramm; Barbara Eisenmann de Torres; Peter R Galle; Ian McFarlane; Hans-Peter Dienes; Ansgar W Lohse
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

Review 10.  Human rights and access to hepatitis C treatment for people who inject drugs.

Authors:  D Wolfe; N Luhmann; M Harris; A Momenghalibaf; E Albers; J Byrne; T Swan
Journal:  Int J Drug Policy       Date:  2015-06-23
View more
  11 in total

1.  S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder.

Authors:  Jennifer M Loftis; Juno Valerio; Jonathan Taylor; Elaine Huang; Rebekah Hudson; Patricia Taylor-Young; Michael Chang; Samuel B Ho; Eric Dieperink; Juan Luis Miranda; Peter Hauser
Journal:  Alcohol Clin Exp Res       Date:  2018-06-28       Impact factor: 3.455

2.  Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction.

Authors:  Jyoti Barokar; Allen McCutchan; Reena Deutsch; Bin Tang; Mariana Cherner; Ajay R Bharti
Journal:  J Neurovirol       Date:  2019-07-07       Impact factor: 2.643

3.  Neuroinvasion and cognitive impairment in comorbid alcohol dependence and chronic viral infection: An initial investigation.

Authors:  Jennifer M Loftis; Jonathan Taylor; Rebekah Hudson; Evan J Firsick
Journal:  J Neuroimmunol       Date:  2019-07-10       Impact factor: 3.478

4.  Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV/HIV coinfected patients: effect on cognitive function, fatigue, and mental health.

Authors:  Felix Kleefeld; Sophie Heller; Patrick Ingiliz; Heiko Jessen; Anders Petersen; Ute Kopp; Antje Kraft; Katrin Hahn
Journal:  J Neurovirol       Date:  2018-05-21       Impact factor: 2.643

Review 5.  Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns.

Authors:  Ameer Abutaleb; Sarah Kattakuzhy; Shyam Kottilil; Erin O'Connor; Eleanor Wilson
Journal:  J Neurovirol       Date:  2018-10-05       Impact factor: 2.643

6.  Neuroimaging and Cognitive Evidence for Combined HIV-Alcohol Effects on the Central Nervous System: A Review.

Authors:  Mark K Britton; Eric C Porges; Vaughn Bryant; Ronald A Cohen
Journal:  Alcohol Clin Exp Res       Date:  2020-12-30       Impact factor: 3.928

Review 7.  The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.

Authors:  Natalie M Zahr
Journal:  Front Aging Neurosci       Date:  2018-03-22       Impact factor: 5.750

8.  Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study.

Authors:  Isak Sundberg; Anders Lannergård; Mia Ramklint; Janet L Cunningham
Journal:  BMC Psychiatry       Date:  2018-05-29       Impact factor: 3.630

Review 9.  Psychosocial and Neurocognitive Factors Associated With Hepatitis C - Implications for Future Health and Wellbeing.

Authors:  David Pires Barreira; Rui Tato Marinho; Manuel Bicho; Renata Fialho; Silvia Raquel Soares Ouakinin
Journal:  Front Psychol       Date:  2019-01-09

10.  Hepatitis C Pretreatment Profile and Gender Differences: Cognition and Disease Severity Effects.

Authors:  David Pires Barreira; Rui Tato Marinho; Manuel Bicho; Isabel Flores; Renata Fialho; Sílvia Ouakinin
Journal:  Front Psychol       Date:  2019-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.